Q32 Bio Stock Forecast - Naive Prediction
| QTTB Stock | 3.93 0.17 4.15% |
The Naive Prediction forecasted value of Q32 Bio on the next trading day is expected to be 4.30 with a mean absolute deviation of 0.23 and the sum of the absolute errors of 14.30. Q32 Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Q32 Bio stock prices and determine the direction of Q32 Bio's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Q32 Bio's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the rsi of Q32 Bio's share price is below 20 indicating that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.71) | EPS Estimate Current Year (2.75) | EPS Estimate Next Year (2.60) | Wall Street Target Price 15 | EPS Estimate Current Quarter (1.19) |
Using Q32 Bio hype-based prediction, you can estimate the value of Q32 Bio from the perspective of Q32 Bio response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Q32 Bio on the next trading day is expected to be 4.30 with a mean absolute deviation of 0.23 and the sum of the absolute errors of 14.30. Q32 Bio after-hype prediction price | USD 3.86 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Q32 Bio to cross-verify your projections. Q32 Bio Additional Predictive Modules
Most predictive techniques to examine Q32 price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Q32 using various technical indicators. When you analyze Q32 charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Q32 Bio Cash Forecast
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Q32 Bio's financial statements to predict how it will affect future prices.
Cash | First Reported 2017-12-31 | Previous Quarter 54.8 M | Current Value 49 M | Quarterly Volatility 56.7 M |
Q32 Bio Naive Prediction Price Forecast For the 26th of January
Given 90 days horizon, the Naive Prediction forecasted value of Q32 Bio on the next trading day is expected to be 4.30 with a mean absolute deviation of 0.23, mean absolute percentage error of 0.1, and the sum of the absolute errors of 14.30.Please note that although there have been many attempts to predict Q32 Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Q32 Bio's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Q32 Bio Stock Forecast Pattern
| Backtest Q32 Bio | Q32 Bio Price Prediction | Buy or Sell Advice |
Q32 Bio Forecasted Value
In the context of forecasting Q32 Bio's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Q32 Bio's downside and upside margins for the forecasting period are 0.04 and 14.95, respectively. We have considered Q32 Bio's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Q32 Bio stock data series using in forecasting. Note that when a statistical model is used to represent Q32 Bio stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 115.8036 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.2345 |
| MAPE | Mean absolute percentage error | 0.0841 |
| SAE | Sum of the absolute errors | 14.3018 |
Predictive Modules for Q32 Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Q32 Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Q32 Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Q32 Bio After-Hype Price Prediction Density Analysis
As far as predicting the price of Q32 Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Q32 Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Q32 Bio, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Q32 Bio Estimiated After-Hype Price Volatility
In the context of predicting Q32 Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Q32 Bio's historical news coverage. Q32 Bio's after-hype downside and upside margins for the prediction period are 0.19 and 14.59, respectively. We have considered Q32 Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Q32 Bio is very risky at this time. Analysis and calculation of next after-hype price of Q32 Bio is based on 3 months time horizon.
Q32 Bio Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Q32 Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Q32 Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Q32 Bio, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.97 | 10.64 | 0.07 | 0.13 | 3 Events / Month | 7 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.93 | 3.86 | 1.78 |
|
Q32 Bio Hype Timeline
Q32 Bio is at this time traded for 3.93. The entity has historical hype elasticity of -0.07, and average elasticity to hype of competition of -0.13. Q32 is anticipated to decline in value after the next headline, with the price expected to drop to 3.86. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -1.78%, whereas the daily expected return is at this time at 0.97%. The volatility of related hype on Q32 Bio is about 7654.68%, with the expected price after the next announcement by competition of 3.80. About 64.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 3.4. Q32 Bio had not issued any dividends in recent years. The entity had 1:18 split on the 26th of March 2024. Given the investment horizon of 90 days the next anticipated press release will be in about 3 days. Check out Historical Fundamental Analysis of Q32 Bio to cross-verify your projections.Q32 Bio Related Hype Analysis
Having access to credible news sources related to Q32 Bio's direct competition is more important than ever and may enhance your ability to predict Q32 Bio's future price movements. Getting to know how Q32 Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Q32 Bio may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| NXTC | NextCure | (0.07) | 26 per month | 6.32 | 0.05 | 11.65 | (8.43) | 42.68 | |
| BOLD | Boundless Bio Common | 0.06 | 4 per month | 0.00 | (0.06) | 4.24 | (5.11) | 16.75 | |
| SABS | SAB Biotherapeutics | (0.07) | 8 per month | 2.94 | 0.12 | 7.97 | (4.05) | 22.52 | |
| ANTX | AN2 Therapeutics | (0.02) | 10 per month | 3.32 | (0.01) | 5.56 | (4.58) | 32.31 | |
| VRCA | Verrica Pharmaceuticals | (0.44) | 10 per month | 5.13 | 0.12 | 13.76 | (9.82) | 52.65 | |
| PSTV | Plus Therapeutics | (0.07) | 6 per month | 0.00 | (0.14) | 8.93 | (8.82) | 48.30 | |
| GBIO | Generation Bio Co | (0.06) | 9 per month | 0.00 | (0.09) | 3.39 | (3.99) | 12.30 | |
| INTS | Intensity Therapeutics Common | (0.07) | 3 per month | 8.62 | 0.09 | 12.20 | (14.04) | 433.59 | |
| ITRM | Iterum Therapeutics PLC | (0.07) | 12 per month | 0.00 | (0.17) | 9.38 | (8.82) | 28.58 | |
| SONN | Sonnet Biotherapeutics Holdings | (0.58) | 8 per month | 0.00 | (0.02) | 19.48 | (18.21) | 69.59 |
Other Forecasting Options for Q32 Bio
For every potential investor in Q32, whether a beginner or expert, Q32 Bio's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Q32 Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Q32. Basic forecasting techniques help filter out the noise by identifying Q32 Bio's price trends.Q32 Bio Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Q32 Bio stock to make a market-neutral strategy. Peer analysis of Q32 Bio could also be used in its relative valuation, which is a method of valuing Q32 Bio by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Q32 Bio Market Strength Events
Market strength indicators help investors to evaluate how Q32 Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Q32 Bio shares will generate the highest return on investment. By undertsting and applying Q32 Bio stock market strength indicators, traders can identify Q32 Bio entry and exit signals to maximize returns.
Q32 Bio Risk Indicators
The analysis of Q32 Bio's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Q32 Bio's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting q32 stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.3 | |||
| Semi Deviation | 5.62 | |||
| Standard Deviation | 10.58 | |||
| Variance | 111.92 | |||
| Downside Variance | 43.49 | |||
| Semi Variance | 31.62 | |||
| Expected Short fall | (6.31) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Q32 Bio
The number of cover stories for Q32 Bio depends on current market conditions and Q32 Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Q32 Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Q32 Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Q32 Bio Short Properties
Q32 Bio's future price predictability will typically decrease when Q32 Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Q32 Bio often depends not only on the future outlook of the potential Q32 Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Q32 Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 12.2 M | |
| Cash And Short Term Investments | 78 M |
Check out Historical Fundamental Analysis of Q32 Bio to cross-verify your projections. For information on how to trade Q32 Stock refer to our How to Trade Q32 Stock guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Q32 Bio. If investors know Q32 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Q32 Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Q32 Bio is measured differently than its book value, which is the value of Q32 that is recorded on the company's balance sheet. Investors also form their own opinion of Q32 Bio's value that differs from its market value or its book value, called intrinsic value, which is Q32 Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Q32 Bio's market value can be influenced by many factors that don't directly affect Q32 Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Q32 Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Q32 Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Q32 Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.